Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.0167 | 1 | 1 |
Echinococcus multilocularis | G protein coupled receptor kinase 6 | 0.014 | 0.5902 | 1 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.014 | 0.5902 | 0.3056 |
Loa Loa (eye worm) | G protein-coupled receptor kinase 1 | 0.014 | 0.5902 | 0.3056 |
Echinococcus granulosus | [G-protein-coupledreceptor] kinase | 0.014 | 0.5902 | 1 |
Echinococcus multilocularis | beta adrenergic receptor kinase | 0.0128 | 0.4098 | 0.6944 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0167 | 1 | 1 |
Echinococcus granulosus | beta-adrenergic receptor kinase | 0.0128 | 0.4098 | 0.6944 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1600 uM | Inhibition of bovine cerebral cortex GRK2 assessed as decrease in phosphorylation of beta-adrenoceptor in presence of [gamma-32P]-ATP by SDS-PAGE analysis | LITERATURE. | 27362616 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.